πŸ‡ΊπŸ‡Έ FDA
Patent

US 11077101

Compounds and methods of use

granted A61KA61K31/4725A61K31/496

Quick answer

US patent 11077101 (Compounds and methods of use) held by Tango Therapeutics, Inc. expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Tango Therapeutics, Inc.
Grant date
Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
43
CPC classes
A61K, A61K31/4725, A61K31/496, A61K31/5377, A61K31/5386